Novogene Co., Ltd. (SHA:688315)
China · Delayed Price · Currency is CNY 16.08
-0.23 (-1.41%)
Aug 8, 2025, 3:00 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Sequencing Platform Service | 952.58M | Log In | Log In | Log In | Log In | Upgrade |
Sequencing Platform Service Growth | 14.05% | Log In | Log In | Log In | Log In | Upgrade |
Life Science Basic Research Services | 635.64M | Log In | Log In | Log In | Log In | Upgrade |
Life Science Basic Research Services Growth | -0.94% | Log In | Log In | Log In | Log In | Upgrade |
Medical Research and Technical Services | 269.25M | Log In | Log In | Log In | Log In | Upgrade |
Medical Research and Technical Services Growth | 6.60% | Log In | Log In | Log In | Log In | Upgrade |
Other Business | 4.61M | Log In | Log In | Log In | Log In | Upgrade |
Other Business Growth | 436.74% | Log In | Log In | Log In | Log In | Upgrade |
Other | 140.03M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -28.28% | Log In | Log In | Log In | Log In | Upgrade |
New Coronavirus Nucleic Acid Detection | - | Log In | Log In | Log In | Log In | Upgrade |
Other Instruments and Consumables | - | Log In | Log In | Log In | Log In | Upgrade |
Other Instruments and Consumables Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other Reagents | - | Log In | Log In | Log In | Log In | Upgrade |
Other Reagents Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Human EGFR, KRAS, BRAF, PIK3CA, ALK, ROS1 Gene Mutation Test (Semiconductor Sequencing Method) | - | Log In | Log In | Log In | Log In | Upgrade |
Human EGFR, KRAS, BRAF, PIK3CA, ALK, ROS1 Gene Mutation Test (Semiconductor Sequencing Method) Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other Operating Income | - | Log In | Log In | Log In | Log In | Upgrade |
Other Operating Income Growth | - | Log In | Log In | Log In | Log In | Upgrade |
DA8600 Sequencer | - | Log In | Log In | Log In | Log In | Upgrade |
DA8600 Sequencer Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Digital PCR Chip Reader | - | Log In | Log In | Log In | Log In | Upgrade |
Digital PCR Chip Reader Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
China | 1.02B | Log In | Log In | Log In | Log In | Upgrade |
China Growth | -9.02% | Log In | Log In | Log In | Log In | Upgrade |
Hong Kong, Macau,Taiwan and Overseas | 985.36M | Log In | Log In | Log In | Log In | Upgrade |
Hong Kong, Macau,Taiwan and Overseas Growth | 22.06% | Log In | Log In | Log In | Log In | Upgrade |